Gemcitabine, a rare cause of chemotherapy-related reticulate hyperpigmentation. Dermatology Reports, [S. l.], v. 16, n. 3, 2024. DOI: 10.4081/dr.2024.9872. Disponível em: https://journals.pagepress.org/dr/article/view/9872. Acesso em: 19 jun. 2025.